We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-9.83%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$370M
AUM Growth
+$33.7M
Cap. Flow
+$6.99M
Cap. Flow %
1.89%
Top 10 Hldgs %
68.63%
Holding
64
New
13
Increased
12
Reduced
8
Closed
16

Top Buys

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$16.2M
2
SNN icon
Smith & Nephew
SNN
+$14.5M
3
VXRT
Vaxart
VXRT
+$12.3M
4
ZBH icon
Zimmer Biomet
ZBH
+$9.56M
5
ABT icon
Abbott
ABT
+$9.49M

Top Sells

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$21.1M
2
CI icon
Cigna
CI
+$17M
3
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$13.6M
4
MDT icon
Medtronic
MDT
+$9.15M
5
EMBC icon
Embecta
EMBC
+$7.77M

Sector Composition

Rank Sector Weight
1 Healthcare 69.35%
2 Consumer Staples 2.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GMED icon
51
Globus Medical
GMED
$10.7B
– –
-393,420
Closed -$21.1M
HCSG icon
52
Healthcare Services Group
HCSG
$1.6B
– –
-421,317
Closed -$5.26M
HUMA icon
53
Humacyte
HUMA
$176M
– –
-2,000,000
Closed -$6.22M
IART icon
54
Integra LifeSciences
IART
$1.29B
– –
-137,000
Closed -$4.86M
IDYA icon
55
IDEAYA Biosciences
IDYA
$3.42B
– –
-33,007
Closed -$1.45M
IRWD icon
56
Ironwood Pharmaceuticals
IRWD
$696M
– –
-149,400
Closed -$1.3M
IRWD icon
57
PUT
Ironwood Pharmaceuticals
IRWD
$696M
– –
-970,800
Closed -$8.46M
MDGL icon
58
Madrigal Pharmaceuticals
MDGL
$10.8B
– –
-51,000
Closed -$13.6M
MDT icon
59
Medtronic
MDT
$109B
– –
-105,000
Closed -$9.15M
OCUL icon
60
Ocular Therapeutix
OCUL
$1.79B
– –
-383,026
Closed -$3.49M
SRRK icon
61
Scholar Rock
SRRK
$5.67B
– –
-273,720
Closed -$4.86M
RVNC
62
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-468,871
Closed -$2.31M
VINC
63
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
– –
-5,102
Closed -$516K
FUSN
64
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-243,035
Closed -$5.18M
1 2
3

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Sio Capital Management held 64 positions worth $370M, up 10% from $336M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Sio Capital Management's Q2 2024 filing shows 13 new, 12 increased, 8 reduced and 16 closed positions. Its largest new stake was Smith & Nephew: 579,619 shares worth $14.4M. The largest sale was Globus Medical, an estimated $21.1M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 85% a quarter earlier, followed by Consumer Staples.

  • Sio Capital Management's largest Q2 2024 buy was Smith & Nephew: 579,619 shares worth $14.4M.
  • Sio Capital Management added most to Teleflex in Q2 2024, an estimated $16.2M increase.
  • Sio Capital Management's biggest Q2 2024 reduction was Cigna, cutting an estimated $17M.
  • Sio Capital Management fully exited Globus Medical in Q2 2024, selling an estimated $21.1M.
  • Sio Capital Management's ten largest holdings make up 69% of its $370M portfolio in Q2 2024.
  • Sio Capital Management opened 13 new positions and closed 16 in Q2 2024.
  • Sio Capital Management's portfolio value rose 10% quarter-over-quarter to $370M.

Based on Sio Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.